Clinical Trials

24 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03682029 2024-04-17

EVITA

Phase NA Unknown

109 enrolled

Cytopenia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT04460950 2024-04-10

Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

237 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03291444 2024-03-15

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

30 enrolled

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04021368 2024-02-14

RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome

112 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05641259 2024-02-02

A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

198 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT04358393 2024-02-01

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

69 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06218771 2024-01-23

A Study of TQB3454 Tablets in Patients With Blood Tumors

80 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04284228 2024-01-16

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

22 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06008405 2023-09-06

Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

48 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05005299 2023-08-01

VICTORY

LymphoidMyeloidOther hematologic neoplasmPlasma cell

18 enrolled

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05970822 2023-08-01

Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML

32 enrolled

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT05140811 2023-05-24

A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

126 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05823714 2023-04-21

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

70 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05448599 2023-03-15

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

120 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04226768 2022-10-04

Enhanced Palliative Care in MDS and AML

Phase NA Unknown

90 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05426798 2022-06-22

Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes

73 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT04764513 2022-03-28

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Lymphoma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05175508 2022-01-03

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Phase 2/3 Unknown

180 enrolled

Frailty, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT05066958 2021-10-04

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Virus Diseases, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05061147 2021-10-01

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

100 enrolled

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04370457 2021-08-04

MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies

Phase NA Unknown

300 enrolled

Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04429191 2021-06-11

JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Classical hematologyMyeloidOther hematologic neoplasm

40 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04906031 2021-06-09

Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

5 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

102 enrolled 12 charts

Phase EARLY_PHASE1 Unknown

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

NCT03795779 2021-05-19

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT02124174 2021-04-26

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Classical hematologyMyeloidOther hematologic neoplasm

50 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03800095 2021-03-24

CALVI

Phase 3 Unknown

140 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms

NCT03083054 2020-10-12

Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

5 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04517175 2020-08-18

Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?

Classical hematologyMyeloidOther hematologic neoplasm

300 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02856464 2020-04-02

PRO-DLI

124 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01619761 2020-02-11

NK Cells in Cord Blood Transplantation

13 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02272478 2020-01-23

AML18

Phase 2/3 Unknown

1,600 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00525746 2020-01-14

Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)

191 enrolled

Phase EARLY_PHASE1 Unknown

Leukemia, Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute

NCT04156256 2019-11-12

CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT03836690 2019-10-25

ToTem

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

18 enrolled

Primary Immunodeficiency Diseases, Anemia, Aplastic, Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT04060485 2019-08-19

Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

Classical hematologyMyeloidOther hematologic neoplasm

1,000 enrolled

Anemia, Aplastic, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT01211457 2019-07-16

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

65 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT03978364 2019-06-07

A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC

Phase 3 Unknown

100 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01240525 2019-02-12

ProT4

LymphoidMyeloidOther hematologic neoplasmPlasma cell

114 enrolled

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile

NCT03454984 2018-11-15

SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

40 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02717884 2018-10-18

TRANSATRA

60 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT03659084 2018-09-06

GREFFE

150 enrolled

Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03655145 2018-08-31

MacHaploMud

Phase 3 Unknown

344 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03235973 2018-06-28

CEREAL

29 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02576301 2018-06-04

AML

105 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01451268 2018-03-20

PANOBEST

62 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03091933 2017-12-06

GLIDE

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03356080 2017-11-29

DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess

50 enrolled